Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$6.69 - $11.99 $38,199 - $68,462
5,710 Added 50.45%
17,028 $145,000
Q1 2023

Apr 26, 2023

SELL
$8.44 - $13.47 $27,067 - $43,198
-3,207 Reduced 22.08%
11,318 $104,000
Q4 2022

Feb 09, 2023

BUY
$9.71 - $15.86 $2,476 - $4,044
255 Added 1.79%
14,525 $148,000
Q3 2022

Nov 09, 2022

BUY
$10.96 - $15.45 $28,978 - $40,849
2,644 Added 22.74%
14,270 $210,000
Q2 2022

Aug 04, 2022

BUY
$7.41 - $11.56 $4,416 - $6,889
596 Added 5.4%
11,626 $149,000
Q1 2022

May 20, 2022

BUY
$9.89 - $17.25 $4,648 - $8,107
470 Added 4.45%
11,030 $106,000
Q4 2021

Feb 15, 2022

BUY
$16.14 - $25.04 $19,965 - $30,974
1,237 Added 13.27%
10,560 $153,000
Q3 2021

Nov 12, 2021

BUY
$17.52 - $27.93 $163,338 - $260,391
9,323 New
9,323 $199,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $851M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.